Evaluation of five staging systems in 470 patients with multiple myeloma

Haematologica

Volumn 91, Issue 8, 2006, Pages 1149-1150

  Mihou, Dimitra ^a   Katodritou, Irene ^a   Zervas, Kostas ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

Myeloma; Prognosis; Staging

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; HUMAN; MULTIPLE MYELOMA; PROGNOSIS;

HUMANS; MULTIPLE MYELOMA; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33746976661     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Durie BGM, Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975;36:842-54.
2. Gassman W, Pralle H, Haferlach T, Pandurevic S, Graubner M, Schmitz N, et al. Staging systems for multiple myeloma: a comparison. Br J Haematol 1985;59:703-11.
3. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. N Engl J Med 1996;335:91-7.
4. Bataille R, Durie BG, Grenier J. Serum β2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging. Br J Haematol 1983;55:439-47.
5. Cuzick J, De Stavola BL, Cooper EH, Chapman C, Mac Lennan IC. Long-term prognostic value of serum β2 microglobulin in myelomatosis. Br J Haematol 1990;75:506-10.
6. Bataille R, Jourdan M, Zhang XG, Klein B. Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias. J Clin Invest 1989;84:2008-11.
7. Bataille R, Durie GM, Grenier J, Sany J. Prognostic factors and staging in multiple myeloma. A reappraisal. J Clin Oncol 1986;4:80-7.
8. Jacobson JL, Hussein MA, Barlogie B, Durie BGM, Crowley JJ. A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience. Br J Haematol 2003;122:441-50.
9. Greipp PR, San Miguel J, Durie BGM, Crowley J, Barlogie B, Bladé J, et al. International Staging System for multiple myeloma. J Clin Oncol 2005;23:3412-20.
10. Weber D, Wang M, Delasalle K, Alexanian R. Confirmation of prognostic value of model using β2 microglobulin (β2 M) and albumin for multiple myeloma (MM) proposed by the International Myeloma Working Group (IMWG) with similar results using β2 M alone. Blood 2003;102[abstract].